Delivery Order SPE2DB24D2003-SPE2DB24FXGW5

Award Date 9/16/24
Potential Completion Date 9/17/24
Potential Value $14K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of ATOVAQUONE-PROGUANIL 250-100 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,455.09 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and is set to be completed by November 27, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,766.96, is for the delivery of Atovaquone-Proguanil 250-100 100S, a prescription medication, to support military healthcare programs. The contract is a delivery order awarded under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $10,464.53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Atovaquone-Proguanil 250-100 100s, a pharmaceutical product, with an ultimate completion date of October 31, 2023. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
This federal contract award, valued at $4,764.05, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ATOVAQUONE-PROGUANIL 250-100 100S, a pharmaceutical product, and has a completion date of March 21, 2025. The award is a delivery order contract, with a firm fixed price pricing type. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $1,723.13 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of atovaquone-proguanil 250-100 100s. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,470.71 firm fixed-price delivery order is for the supply of ATOVAQUONE-PROGUANIL 250-100 100S, a medical commodity used in the prevention and treatment of malaria. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,568,173,842 units of the pharmaceutical product Atovaquone-Proguanil 250-100 100s. The delivery order has a ceiling value of $1,160.03 and is a firm fixed-price contract. This award is not a set-aside and is part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award, valued at $5,586.14, was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, awarded by the Defense Logistics Agency (DLA), is a Delivery Order with a Firm Fixed Price pricing type. The award supports the procurement of ATOVAQUONE-PROGUANIL 250-100 100S, a pharmaceutical product, with an ultimate completion date of January 16, 2025. The contract does not have a set-aside designation, indicating...
This federal contract award, valued at $1,439.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ATOVAQUONE-PROGUANIL 250-100 100S, a pharmaceutical product, and is a Firm Fixed Price Delivery Order with an ultimate completion date of December 5, 2024. The contract is not designated with any set-aside requirements, indicating open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $35,862.01 delivery order contract is for the supply of ATOVAQUONE-PROGUANIL 250-100 100S, a malaria preventative medication. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen holds a larger $999,999,999 Indefinite...
  • SPE2DB24D2003
    Indefinite Delivery Contract
  • SPE2DB24D2003-SPE2DB24FXGW5
    Delivery Order

This federal contract award is a delivery order with a firm fixed price valued at $14,414.31 that was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of 4565826799 ATOVAQUONE-PROGUANIL 250-100 100S, a prescription medication. This award is a child contract under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation and is scheduled for completion on September 17, 2024.

Generated 12/16/24, 2:03 PM